InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

MIMEDX GROUP, INC.

MDXG Clue Score68
United States Fiscal year ends December CIK 0001376339
$4.67 +1.08% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.67 −20.17% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue221.7Operating income0.9Net income0.4EPS, diluted0.00Fiscal year 2017Revenue321.1 +44.8%Operating income46.2Net income64.7 +16,496.7%EPS, diluted0.56Fiscal year 2018Revenue359.1 +11.8%Operating income−3.9Net income−30.0 −146.3%EPS, diluted−0.28 −150.0%Fiscal year 2019Revenue299.3 −16.7%Operating income−21.2Net income−25.6EPS, diluted−0.24Fiscal year 2020Revenue248.2 −17.0%Operating income−45.4Net income−49.3EPS, diluted−0.77Fiscal year 2021Revenue242.0 −2.5%Operating income−7.1Net income−10.3EPS, diluted−0.15Fiscal year 2022Revenue267.8 +10.7%Operating income−14.7Net income−30.2EPS, diluted−0.33Fiscal year 2023Revenue321.5 +20.0%Operating income37.1Net income58.2EPS, diluted0.37Fiscal year 2024Revenue348.9 +8.5%Operating income58.9Net income42.4 −27.2%EPS, diluted0.28 −24.3%Fiscal year 2025Revenue418.6 +20.0%Operating income63.9Net income48.6 +14.5%EPS, diluted0.32 +14.3%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 221.7 321.1 359.1 299.3 248.2 242.0 267.8 321.5 348.9 418.6
Growth +44.8% +11.8% −16.7% −17.0% −2.5% +10.7% +20.0% +8.5% +20.0%
Operating income 0.9 46.2 −3.9 −21.2 −45.4 −7.1 −14.7 37.1 58.9 63.9
Net income 0.4 64.7 −30.0 −25.6 −49.3 −10.3 −30.2 58.2 42.4 48.6
Growth +16,496.7% −146.3% −27.2% +14.5%
EPS, diluted 0.00 0.56 −0.28 −0.24 −0.77 −0.15 −0.33 0.37 0.28 0.32
Growth −150.0% −24.3% +14.3%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin86.0%Operating margin0.4%Net margin0.2%Fiscal year 2017Gross margin89.0%Operating margin14.4%Net margin20.2%Fiscal year 2018Gross margin89.9%Operating margin−1.1%Net margin−8.3%Fiscal year 2019Gross margin85.6%Operating margin−7.1%Net margin−8.5%Fiscal year 2020Gross margin84.2%Operating margin−18.3%Net margin−19.9%Fiscal year 2021Gross margin83.6%Operating margin−2.9%Net margin−4.2%Free cash flow margin−2.1%Fiscal year 2022Gross margin82.0%Operating margin−5.5%Net margin−11.3%Free cash flow margin−7.2%Fiscal year 2023Gross margin83.0%Operating margin11.5%Net margin18.1%Free cash flow margin7.7%Fiscal year 2024Gross margin82.8%Operating margin16.9%Net margin12.2%Fiscal year 2025Gross margin82.6%Operating margin15.3%Net margin11.6%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 86.0% 89.0% 89.9% 85.6% 84.2% 83.6% 82.0% 83.0% 82.8% 82.6%
Operating margin 0.4% 14.4% −1.1% −7.1% −18.3% −2.9% −5.5% 11.5% 16.9% 15.3%
Net margin 0.2% 20.2% −8.3% −8.5% −19.9% −4.2% −11.3% 18.1% 12.2% 11.6%
Free cash flow margin n/a n/a n/a n/a n/a −2.1% −7.2% 7.7% n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow23.8Buybacks−10.4Fiscal year 2017Operating cash flow62.9Buybacks−68.3Fiscal year 2018Operating cash flow35.8Buybacks−7.6Fiscal year 2019Operating cash flow−39.4Fiscal year 2020Operating cash flow−30.3Buybacks−0.9Fiscal year 2021Operating cash flow−2.0Capital expenditure−3.2Free cash flow−5.2Buybacks0.0Fiscal year 2022Operating cash flow−17.9Capital expenditure−1.5Free cash flow−19.4Buybacks0.0Fiscal year 2023Operating cash flow26.8Capital expenditure−2.0Free cash flow24.8Buybacks−9.5Fiscal year 2024Operating cash flow66.2Buybacks0.0Fiscal year 2025Operating cash flow74.0Buybacks0.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 23.8 62.9 35.8 −39.4 −30.3 −2.0 −17.9 26.8 66.2 74.0
Capital expenditure n/a n/a n/a n/a n/a −3.2 −1.5 −2.0 n/a n/a
Free cash flow n/a n/a n/a n/a n/a −5.2 −19.4 24.8 n/a n/a
Growth
Buybacks −10.4 −68.3 −7.6 n/a −0.9 0.0 0.0 −9.5 0.0 0.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash30.3Shareholders’ equity48.1Fiscal year 2017Cash27.5Shareholders’ equity73.8Fiscal year 2018Cash45.1Total debt0.0Net cash (debt)45.1Shareholders’ equity49.7Debt to equity0.00Fiscal year 2019Cash69.1Total debt65.7Net cash (debt)3.4Shareholders’ equity34.4Debt to equity1.91Fiscal year 2020Cash95.8Total debt47.7Net cash (debt)48.1Shareholders’ equity−0.2Fiscal year 2021Cash87.1Total debt48.1Net cash (debt)39.0Shareholders’ equity0.1Debt to equity586.91Fiscal year 2022Cash66.0Total debt48.6Net cash (debt)17.4Shareholders’ equity−18.0Fiscal year 2023Cash82.0Total debt49.1Net cash (debt)32.9Shareholders’ equity142.7Debt to equity0.34Fiscal year 2024Cash104.4Total debt18.8Net cash (debt)85.6Shareholders’ equity193.1Debt to equity0.10Fiscal year 2025Cash166.1Total debt18.0Net cash (debt)148.2Shareholders’ equity256.5Debt to equity0.07
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 30.3 27.5 45.1 69.1 95.8 87.1 66.0 82.0 104.4 166.1
Total debt n/a n/a 0.0 65.7 47.7 48.1 48.6 49.1 18.8 18.0
Net cash (debt) n/a n/a 45.1 3.4 48.1 39.0 17.4 32.9 85.6 148.2
Shareholders’ equity 48.1 73.8 49.7 34.4 −0.2 0.1 −18.0 142.7 193.1 256.5
Debt to equity n/a n/a 0.00 1.91 n/a 586.91 n/a 0.34 0.10 0.07

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
221.7 321.1 359.1 299.3 248.2 242.0 267.8 321.5 348.9 418.6
Growth +44.8% +11.8% −16.7% −17.0% −2.5% +10.7% +20.0% +8.5% +20.0%
30.9 35.2 36.4 43.1 39.3 39.6 48.3 54.6 60.1 73.0
190.8 285.9 322.7 256.2 208.9 202.4 219.5 266.8 288.8 345.6
Growth +49.9% +12.9% −20.6% −18.5% −3.1% +8.5% +21.6% +8.2% +19.7%
14.3 17.9 15.8 11.1 11.7 9.9 12.7 12.7 12.3 15.1
173.4 220.1 258.5 198.2 181.0 194.8 208.7 211.1 225.1 266.2
0.9 46.2 −3.9 −21.2 −45.4 −7.1 −14.7 37.1 58.9 63.9
Growth +5,128.8% −108.5% +58.6% +8.5%
0.5 45.1 −3.4 −25.6 −61.5 −12.1 −19.7 30.6 57.3 66.3
0.2 −19.6 26.6 −0.0 −12.3 0.2 0.2 −36.8 15.3 17.7
0.4 64.7 −30.0 −25.6 −49.3 −10.3 −30.2 58.2 42.4 48.6
Growth +16,496.7% −146.3% −27.2% +14.5%
Per share
0.00 0.61 −0.28 −0.24 −0.77 −0.15 −0.33 0.40 0.29 0.33
0.00 0.56 −0.28 −0.24 −0.77 −0.15 −0.33 0.37 0.28 0.32
Growth −150.0% −24.3% +14.3%
105.9 106.1 105.6 106.9 108.3 110.4 112.9 116.5 147.0 147.8
112.6 116.1 105.6 106.9 108.3 110.4 112.9 146.0 149.0 149.7
Growth +3.1% −9.1% +1.3% +1.2% +1.9% +2.3% +29.3% +2.1% +0.5%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 11.0% a year over five years.
  • The diluted share count rose 38.3% in five years, which is dilution.
  • Operating margin is up 33.5 points on five years ago, at 15.3%.
  • A net loss in 5 of 10 years on file.